Clinical Trial Update: Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports results from a Phase 2 study of vismodegib (Erivedge) in pediatric patients with refractory diffuse intrinsic pontine gli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Erivedge (vismodegib)

Snippet

Sponsor: Giselle Sholler | Conditions: Pontine Glioma | Phase 2 | Status: TERMINATED | Results posted: 2016-10-28